EPISODE · Aug 25, 2025 · 55 MIN
Drugging the UnDruggable
from Demy-Colton Talks Biotech · host Demy-Colton
Up to 85% of the human proteome is considered “undruggable,” with proteins that lack the pockets where traditional therapeutics can bind. But that barrier is beginning to shift.A new wave of biotech companies is bringing forward breakthrough technologies designed to target the most elusive proteins—opening the door to therapies once thought impossible. In this episode, we explore the science, innovation, and opportunities behind cracking the code of the so-called “undruggable” proteome.
What this episode covers
Up to 85% of the human proteome is considered “undruggable,” with proteins that lack the pockets where traditional therapeutics can bind. But that barrier is beginning to shift.A new wave of biotech companies is bringing forward breakthrough technologies designed to target the most elusive proteins—opening the door to therapies once thought impossible. In this episode, we explore the science, innovation, and opportunities behind cracking the code of the so-called “undruggable” proteome.
NOW PLAYING
Drugging the UnDruggable
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.